What does Haw Par Corporation Limited do?

Haw Par Corporation Limited (HAWPY) operates in the Drug Manufacturers - General industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is HAWPY's market cap?

Haw Par Corporation Limited (HAWPY) has a market capitalization of approximately $2.96 billion, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does HAWPY pay a dividend?

Yes — Haw Par Corporation Limited (HAWPY) pays a dividend semi-annually, with a trailing-twelve-month yield of 2.34%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

HAWPY

Haw Par Corporation Limited

OTC·Drug Manufacturers, General · Healthcare

$53.50$0.00+0.00%

Market cap$2.96B·Market closed·Aug 25 8:00 PM UTC

Price Chart

$53.50+$0.00 (+0.00%)today

+93.84%CAGR +14.16%

Select date range

FromTo

Apr 3, 2013Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)2.34%

Annual Dividend (FWD)$1.25

Dividend Growth (5Y)+9.5%

Dividend Safety—

Payout Ratio33.3%

FCF Payout Ratio30.2%

Most Recent Dividend$0.625

Ex-Dividend DateAug 25

Payment DateOct 1

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)−8.0%

EPS Growth (3Y)+9.6%

EPS Growth (5Y)+23.0%

Next Earnings DateFeb 19

Last Report DateFeb 19

Reported vs Estimate$1.71

Earnings Surprise—

FinancialsFinancials Tab

RevenueS$220.53M

Net IncomeS$230.02M

Net Margin104.3%

Operating Cash FlowS$231.78M

Capital ExpendituresS$2.44M

Free Cash FlowS$229.34M

Return on Equity4.9%

Return on Invested Capital0.6%

Net CashS$828.06M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for HAWPY and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how HAWPY's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for HAWPY and 80,000+ other tickers.

About Haw Par Corporation Limited

Haw Par Corporation Limited, through its numerous subsidiaries, engages in the creation, distribution, and sale of healthcare products across Singapore, the ASEAN region, other Asian nations, and internationally. Its business is structured into three main divisions: Healthcare, Investments, and a general "Others" category. The Healthcare segment's primary focus is on manufacturing and supplying topical analgesic remedies, notably the prominent Tiger Balm and Kwan Loong brands. The Investments division concentrates predominantly on financial investments, specifically in publicly listed…

CEO: Ee Lim Wee
Sector: Healthcare
Industry: Drug Manufacturers - General
Exchange: OTC
Employees: 595
Website: www.hawpar.com

Peers

HUTCHMED (China) Limited

Latest News

News Tab

No recent news available.

Frequently Asked Questions About HAWPY

What does Haw Par Corporation Limited do?: Haw Par Corporation Limited (HAWPY) operates in the Drug Manufacturers - General industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is HAWPY's market cap?: Haw Par Corporation Limited (HAWPY) has a market capitalization of approximately $2.96 billion, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does HAWPY pay a dividend?: Yes — Haw Par Corporation Limited (HAWPY) pays a dividend semi-annually, with a trailing-twelve-month yield of 2.34%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.